C2C Services & Suppliers
Filter News
Found 110,092 articles
-
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
-
Even though you may have gone through a phone screening that involved answering questions about salary, the subject may come again as the interviewer becomes more interested in hiring you.
-
This article offers a basic roadmap for getting started writing your cover letter for a research scientist job.
-
Bionano Genomics Announces Adoption of Its Saphyr® System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for Clinical Testing
10/16/2019
Successful validation of Saphyr to replace “gold standard” method of southern blotting for molecular diagnosis of FSHD supports broad utility of Saphyr
-
16 Questions Top Pharma Applicants Should Ask During the Job Interview
7/11/2019
-
12 Careers for Life Scientists Outside of the Lab
3/1/2019
Not everyone who completes a life sciences PhD wants to continue working in a laboratory or in research. They may just have grown out of it, or found that the work isn’t what they thought it was, or that they still love science and would rather find a different way of making a living than conducting academic or commercial research.
-
Cannabis Company Starling Brands, Inc. Announces Global Licensing Partnership with Pioneering CBD Brand, Jayden's Juice
1/18/2019
Starling Brands is pleased to announce the expansion of their global licensing, manufacturing and distribution deal with world-renowned brand Jayden's Juice, one of the pioneers in the cannabis CBD movement.
-
Your Feedback Matters! Topics in 2019
1/15/2019
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about. -
Inc. magazine collates an annual list of the fastest-growing private companies in America. This year, 15 of the top 5,000 were related to healthcare, medical devices and biopharma.
-
Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area). Here’s a look at 13 Massachusetts life science companies that are showing both gains and losses—...
-
Expedeon AG adds five new Alexa Fluor labels to its Lightning-Link antibody labeling kit range
8/14/2018
Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced the introduction of five new Alexa Fluor® labels to its range of Lightning-Link® antibody labelling kits.
-
Uni-flo2 Single-Nasal Cannula System Announces White Paper Emphasizing Benefits of Single-Nasal Cannula for Patient Dignity, Comfort and Safety
8/14/2018
Uni-flo2 Single-nasal Cannula System (Uni-flo2), a breakthrough patient-centric solution that ensures continuous oxygen flow equivalent to the low flow dual-pronged cannula but with half the skin contact, announces the release of its white paper, “Breathe Easier: Single-Prong Cannula Represents Important Breakthrough in Oxygen Therapy for COPD Patients.”
-
EB Pure Agarose Gel Extraction Kit Offers Rapid Recovery of Fine Molecules
8/13/2018
Empirical Bioscience announced today that they have introduced the EB Pure Agarose Gel Extraction Kit. The set is designed to quickly isolate small DNA fragments (70 bp to 20 kb) from Agarose Gel in just 15 minutes.
-
MilliporeSigma’s New BioReliance® Rapid Sterility Testing Service Delivers Results in Half the Time as Traditional Methods
8/9/2018
MilliporeSigma has launched its sterility testing service for a direct inoculation method using the BACT/Alert® 3D Rapid Microbial Detection System.
-
GENOMIC VISION AND EUROPEAN EQUITY PARTNERS ENTER INTO AGREEMENT TO USE MOLECULAR COMBING AS A GENOME INTEGRITY ASSAY IN THE FIELD OF BIOMANUFACTURING
8/9/2018
Genomic Vision (FR0011799907 – GV), a company specializing in the development of diagnostic tests for the early detection of cancers and hereditary diseases, and applications for life sciences research, today announces that it has entered into a licensing agreement with European Equity Partners (EEP), a U.K private investment firm focused on life science investments, to use molecular combing technology within the bioprocessing domain.
-
The He Research Group at the Fischell Department of Bioengineering, UMD, uses Linkam temperature- controlled microscopy to study multiscale biomaterials to engineer living cells and tissues for cancer treatment and cell-based medicine.
8/8/2018
Market leaders in temperature-controlled microscopy and leaders in sample characterization solutions, Linkam Scientific Instruments, reports on the research of Professor Xiaoming “Shawn” He of the Fischell Department of Bioengineering at the University of Maryland.
-
BC Platforms and Negen Announce Partnership for Early Risk Assessment of Common Diseases
8/8/2018
- BC Platforms, a world leader in genomic data management and analytics, today announces that it has signed a co-operation agreement with Negen to use its platform to provide detailed insights into raw genomic data for clinical reporting capabilities.
-
TimiHealth Program Empowering Consumers to Profit from their DNA Data Will Be Listed on LATOKEN Where Trading Starts Aug. 9, Part of a Two Million Timicoin Giveaway
8/8/2018
Timicoin/TimiHealth (www.timicoin.io),the first operating blockchain designed to empower individuals through itsTimiDNA platform to own, control, and monetize their genetic DNA data,will also be the first to actually pay them for it via LATOKEN (www.LATOKEN.COM).
-
China is the largest supplier of active pharmaceutical ingredients (API) in the world, supplying 40 percent of APIs to global pharma companies. And a recent series of scandals and issues related to drug manufacturing in China has highlighted how many problems this could cause the global drug supp...
-
MilliporeSigma’s BioReliance® Product Characterization Services Help Ensure Purity, Safety and Efficacy
8/7/2018
MilliporeSigma has launched its BioReliance® Product Characterization Portfolio of tests for quality assessment of biologic drugs.